prepar
sarscov
prepar
describ
previous
gene
encod
clone
viral
cdna
obtain
triservic
gener
hospit
taipei
taiwan
use
pcr
primer
forward
encod
factor
xa
cleavag
site
revers
contain
bamhi
xhoi
restrict
site
underlin
use
pcr
product
digest
bamhi
xhoi
ligat
vector
ge
healthcar
contain
glutathion
stransferas
tag
n
terminu
gene
encod
cvb
clone
viral
cdna
obtain
changgung
memori
hospit
taoyuan
taiwan
pcr
primer
forward
revers
contain
ncoi
xhoi
restrict
site
underlin
use
ctermin
tag
construct
pcr
product
digest
ncoi
xhoi
dna
fragment
clone
novagen
correct
construct
subsequ
transform
escherichia
coli
novagen
protein
express
overnight
cultur
ml
singl
transform
use
inocul
ml
fresh
lb
medium
contain
ampicillin
cell
grown
induc
mm
h
cell
harvest
centrifug
g
min
purif
proteas
conduct
histag
purifi
use
nickelnitrilotriacet
acid
column
elut
mm
trishcl
ph
mm
nacl
mm
imidazol
protein
solut
dialyz
buffer
contain
mm
trishcl
ph
mm
nacl
mm
edta
mm
mm
dithiothreitol
purifi
use
glutathion
stransferas
column
treat
factor
xa
remov
fusion
tag
puriti
improv
buffer
exchang
enzym
qff
column
ge
healthcar
use
buffer
contain
mm
trishcl
ph
mm
edta
mm
dithiothreitol
nacl
mm
trishcl
ph
purifi
protein
concentr
crystal
peptid
synthesi
examin
substrat
peptid
use
test
proteas
substrat
synthes
use
peptid
synthes
appli
biosystem
start
mmol
g
phydroxymethylphenoxymethyl
polystyren
resin
mmolg
synthesi
perform
use
stepwis
fastmoc
protocol
appli
biosystem
amino
acid
introduc
use
manufactur
prepack
cartridg
mmol
mass
spectra
synthes
peptid
obtain
use
finnigan
lcq
mass
spectromet
electrospray
ion
sourc
examin
substrat
specif
proteas
peptid
incub
proteas
h
result
mixtur
analyz
reversephas
hplc
use
mention
condit
peak
area
product
integr
calcul
reaction
rate
peptid
substrat
catalysi
proteas
optim
peptid
substrat
label
fluoresc
quench
pair
therebi
fluorogen
peptid
dabcylktsavlqsgfrkmeedan
could
use
measur
proteas
activ
proteas
activ
use
fluorogen
peptid
kinet
measur
perform
mm
me
ph
optim
ph
proteas
activ
enhanc
fluoresc
due
cleavag
peptid
monitor
nm
excit
nm
use
fluoresc
plate
reader
fluoroskan
ascent
thermo
scientif
enzym
concentr
use
measur
km
kcat
valu
substrat
concentr
km
valu
substrat
concentr
determin
use
extinct
coeffici
nm
edan
nm
dabcyl
initi
rate
within
substrat
consumpt
use
calcul
kinet
paramet
use
michaelismenten
equat
fit
kaleidagraph
comput
program
synergi
softwar
enzym
inhibit
inhibit
constant
measur
reaction
perform
proteas
fluorogen
peptid
buffer
mm
me
ph
fluoresc
chang
result
reaction
follow
time
use
fluoresc
plate
reader
determin
inhibitori
effect
variou
compound
compound
enzym
preincub
min
prior
addit
substrat
inhibit
constant
sar
analyz
reversephas
hplc
use
column
ki
calcul
describ
previous
inhibitor
includ
zinc
nethylnphenyldithiocarbam
epdtc
dissolv
dmso
use
sittingdrop
vapor
diffus
method
enzym
solut
mix
inhibitor
solut
molar
ratio
min
combin
equal
amount
reservoir
crystal
obtain
use
reservoir
peg
dmso
mpd
trishcl
ph
crystal
flashfrozen
ethylen
glycol
vv
cryoprotect
crystal
solut
peg
trishcl
ph
use
reservoir
nativ
crystal
use
peg
trishcl
ph
give
two
monoclin
form
space
group
form
form
ii
second
crystal
form
obtain
enzym
solut
mix
reservoir
volum
ratio
two
crystal
complex
inact
mutant
obtain
use
reservoir
solut
peg
trishcl
ph
crystal
rins
glycerol
cryoprotect
prior
data
collect
crystal
sar
complex
obtain
use
reservoir
solut
peg
dmso
mpd
mm
dithiothreitol
me
ph
cryoprotect
glycerol
ethylen
glycol
diffract
data
collect
cryogen
temperatur
process
scale
use
program
structur
crystal
structur
determin
molecular
replac
use
program
amor
use
swissmodel
server
human
rv
structur
templat
model
gener
solv
epdtc
complex
structur
remain
cv
crystal
structur
solv
use
partial
refin
complex
structur
search
model
sar
complex
structur
use
search
model
molecular
replac
respect
program
cn
crystallographi
nmr
system
use
structur
refin
manual
modif
model
perform
use
program
xtalview
differ
fourier
fo
fc
map
calcul
locat
inhibitor
solvent
molecul
data
collect
final
model
statist
shown
tabl
atom
coordin
structur
factor
variou
structur
deposit
protein
data
bank
see
tabl
detect
coxsackieviru
confluent
human
embryon
rhabdomyosarcoma
cell
plate
infect
mockinfect
coxsackieviru
multipl
infect
treatment
compound
compound
fortyeight
hour
infect
total
cultur
supernat
harvest
cultur
medium
supernat
cell
platelet
disrupt
freezethaw
method
viral
rna
extract
total
cultur
supernat
use
viral
rna
extract
miniprep
system
kit
viogen
sunnyval
ca
protocol
recommend
manufactur
elut
diethylpyrocarbonatetr
water
rtpcr
amplif
perform
use
revers
onestep
rtpcr
kit
abgen
epsom
surrey
uk
use
primer
set
specif
panenteroviru
detect
rtpcr
carri
reaction
mixtur
contain
rna
templat
forward
revers
primer
kitsuppli
enzym
mixtur
rtpcr
master
mix
rt
step
includ
incub
h
min
follow
cycl
min
final
elong
step
min
pcr
product
analyz
gel
electrophoresi
agaros
gel
contain
ethidium
bromid
dna
band
visual
photograph
uv
transillumin
substrat
specif
kinet
peptid
correspond
autoprocess
site
includ
laghq
glptm
qnffq
gpved
dameq
gvkdi
maerq
nnswl
ealfq
gppvi
fagfq
gaytg
vpg
qakvq
gpafe
vpg
fndeq
geief
rnadepend
rna
polymeras
savlq
sgfrk
deriv
ntermin
autoprocess
site
sarscov
almost
contain
gln
follow
small
amino
acid
gli
ser
serv
cleavag
site
test
substrat
proteas
indic
cleavag
site
surprisingli
show
substanti
better
activ
savlq
sgfrk
substrat
sarscov
cleavag
site
base
hplc
assay
fig
therefor
peptid
dabcylktsavlqsgfrkmeedan
fluoresc
quench
pair
dabcyledan
chosen
proteas
activ
assay
monitor
fluoresc
increas
due
peptid
bond
cleavag
real
time
kcat
vmax
e
km
valu
proteas
use
fluorogen
substrat
determin
respect
fig
evalu
show
substrat
specif
similar
sarscov
report
inhibitor
test
recombin
use
fluorogen
substrat
determin
inhibitori
activ
epdtc
inhibit
sar
proteas
ki
show
lower
inhibit
ki
fig
inhibit
pattern
shown
competit
respect
substrat
peptidomimet
inhibitor
ki
valu
sarscov
respect
ki
valu
report
elsewher
larger
ki
valu
four
compound
observ
indic
lower
affin
toward
tabl
similar
structur
differ
extra
cyclopropyl
group
residu
also
possess
similar
potenc
ki
respect
structur
cov
crystal
form
belong
monoclin
space
group
form
form
ii
proteas
obtain
similar
crystal
condit
tabl
form
crystal
two
molecul
per
asymmetr
unit
relat
pseudodyad
form
ii
crystal
one
molecul
shown
fig
structur
adopt
chymotrypsin
protein
fold
similar
rv
viral
proteas
rootmeansquar
deviat
rv
atom
n
terminu
start
residu
follow
two
topolog
equival
domain
compris
residu
pack
togeth
form
extend
shallow
groov
substrat
bind
catalyt
triad
locat
cleft
two
domain
proteas
structur
two
crystal
form
similar
except
loop
residu
disord
side
chain
differ
orient
slightli
shift
form
ii
crystal
fig
loop
flexibl
protein
surfac
may
regul
substrat
bind
variabl
loop
conform
also
observ
structur
footandmouth
diseas
viru
mutant
crystal
unit
cell
similar
wildtyp
form
crystal
diffract
tabl
fig
complex
epdtc
crystal
form
ii
unit
cell
slight
variat
protein
conform
fig
complex
crystal
sarscov
belong
space
group
one
complex
model
per
asymmetr
unit
tabl
structur
inhibitor
well
defin
fourier
map
complex
crystal
unit
cell
dimer
asymmetr
unit
fig
report
previous
sarscov
homodim
three
domain
monom
catalyt
dyad
hisci
locat
activ
site
cleft
domain
ii
wherea
domain
iii
particip
proteas
dimer
contrast
monom
contain
dimer
domain
iii
employ
program
monom
superimpos
onto
sar
rootmeansquar
deviat
match
atom
stringent
criteria
use
catalyt
triad
coincid
almost
perfectli
hisci
dyad
cov
proteas
fig
although
two
type
proteas
share
littl
sequenc
homolog
structurebas
sequenc
comparison
reveal
similar
region
domain
ii
fig
explain
similar
substrat
specif
catalyt
mechan
howev
differ
affin
protein
inhibitor
encourag
analysi
interact
interact
structur
epdtc
shown
fig
peptid
inhibitor
shown
tabl
local
structur
complex
epdtc
shown
fig
b
c
previous
determin
structur
sarscov
complex
epdtc
shown
fig
comparison
environ
peptid
inhibitor
bound
proteas
shown
fig
omit
map
bound
inhibitor
shown
fig
zinc
site
confirm
anomal
differ
fourier
map
shown
bind
mode
epdtc
proteas
similar
observ
sarscov
bind
two
catalyt
residu
cy
zinc
two
sulfur
atom
epdtc
clearli
seen
everi
subunit
bulki
substitu
group
crystal
invis
zinc
center
bond
angl
similar
observ
sarscov
structur
distort
tetrahedr
geometri
observ
fig
angl
despit
restraint
ideal
angl
employ
refin
addit
mpd
molecul
crystal
reservoir
found
one
subunit
locat
pocket
two
oxygen
atom
mpd
form
two
hbond
side
chain
distanc
respect
mpd
bind
similar
posit
dmso
come
solvent
dissolv
inhibitor
sarscov
complex
structur
organ
molecul
observ
complex
structur
epdtc
structur
fig
ethyl
ester
occupi
site
close
proxim
catalyt
center
michael
acceptor
form
coval
bond
lactam
ring
occupi
site
gln
mimic
form
two
hbond
leu
side
chain
occupi
site
larg
hydrophob
pocket
interestingli
group
actual
locat
site
benzoxi
ester
group
lack
strong
electron
densiti
fig
expos
bulk
solvent
fig
two
protein
molecul
structur
superimpos
along
complex
eight
conserv
water
molecul
distanc
less
equival
water
occupi
inhibitor
bind
site
wherea
other
may
help
improv
drugprotein
interact
see
sarscov
structur
fig
attack
keton
posit
form
coval
bond
induc
hydrogen
bond
keton
oxygen
nh
group
pocket
site
carbonyl
oxygen
nitrogen
fivememb
lactam
ring
posit
form
hydrogen
bond
respect
follow
leu
side
chain
bind
hydrophob
pocket
group
direct
toward
bulk
solvent
benzoxi
group
posit
bound
pocket
phenyl
ring
align
parallel
flat
surfac
near
carbon
atom
phenyl
ring
show
hydrophob
contact
protein
structur
sarscov
fig
inhibitor
adopt
similar
bind
mode
structur
structur
peptid
nh
group
residu
form
four
hydrogen
bond
backbon
co
group
side
chain
addit
co
group
interact
nh
group
antivir
compound
effect
inhibit
replic
critic
essenti
step
coxsackieviru
replic
polyprotein
cleavag
viral
protein
translat
potenti
target
antivir
drug
observ
effect
compound
viru
replic
rtpcr
appli
detect
coxsackieviru
genom
infect
cell
shown
fig
dna
fragment
could
detect
virusinfect
cell
either
absenc
presenc
howev
specif
dna
fragment
could
found
concentr
compound
increas
indic
compound
could
effect
block
viral
replic
host
cell
two
kind
proteas
serv
drug
target
develop
inhibitor
picornavirus
coronavirus
respect
although
two
proteas
share
sequenc
homolog
share
similar
substrat
specif
recogn
gln
residu
hydrophob
residu
posit
small
amino
acid
residu
posit
studi
found
actual
prefer
substrat
sarscov
deriv
ntermin
process
site
howev
inhibitor
could
inhibit
proteas
equal
tabl
suggest
structur
differ
activ
site
understand
structur
basi
specif
solv
structur
sarscov
inhibitor
compar
bind
mode
inform
obtain
use
design
specif
inhibitor
kind
proteas
zinccoordin
inhibitor
epdtc
similar
previous
determin
bind
mode
structur
complex
sarscov
cation
tetrahedr
coordin
hisci
catalyt
residu
fig
bind
facilit
suitabl
distanc
nitrogen
atom
anion
cy
zinc
center
proteas
howev
epdtc
inhibit
weaker
fig
probabl
side
chain
hydrogenbond
atom
favor
proton
therefor
atom
must
deproton
epdtc
bind
take
place
lack
electron
densiti
bulki
substitu
group
might
suggest
disord
accord
comput
model
inhibitor
sarscov
entir
epdtc
could
accommod
activ
site
suffici
room
bulki
side
group
rotat
hand
molecul
dmso
sarscov
mpd
bound
site
although
dmso
molecul
form
hydrogen
bond
former
enzym
smaller
side
chain
latter
case
provid
hydrophob
interact
larger
space
mpd
bond
fig
c
solvent
molecul
seen
complex
structur
epdtc
open
pocket
fail
trap
small
molecul
unlik
dimer
subunit
compos
three
domain
monom
two
catalyt
domain
structurebas
sequenc
align
show
larg
loop
wherea
smaller
loop
insert
fig
loop
sarscov
secur
hydrophob
pocket
side
chain
two
loop
also
adjac
activ
site
modul
bind
residu
four
peptidomimet
compound
higher
ki
sarscov
gener
open
activ
site
also
bind
site
differ
peptidomimet
inhibitor
bind
activ
site
sarscov
similar
mode
wherea
bind
differ
cyclohexyl
side
chain
fit
well
site
sarscov
bulki
wherea
leu
fit
well
loop
make
site
shallow
open
fig
consist
higher
ki
tabl
hand
structur
analog
rv
phenyl
side
chain
may
prefer
evidenc
tight
bind
rv
moreov
tbutyl
group
favor
tight
bind
site
sarscov
enhanc
inhibit
convers
val
fit
rv
well
addit
tbutyl
group
make
compound
weaker
inhibitor
tbutyl
group
bulki
residu
actual
reloc
hydrophob
environ
site
form
loop
leav
unbound
benzoxi
group
face
bulk
solvent
fig
may
also
contribut
higher
ki
remov
tbutyl
group
entir
residu
may
improv
inhibitor
inhibitor
site
favor
gln
mimick
lactam
ring
lactam
ring
provid
better
inhibitori
activ
gln
reveal
previous
report
structureact
relationship
strong
bind
lactam
ring
proteas
evidenc
multipl
hydrogen
bond
format
crystal
structur
fig
addit
cyclopropyl
group
residu
enhanc
inhibit
almost
compar
becom
weaker
sarscov
tabl
shown
fig
triangular
group
tend
clash
protein
atom
limit
space
site
adjac
loop
site
open
yet
still
flank
hydrophob
side
chain
conserv
water
molecul
activ
site
reveal
highresolut
crystal
structur
mutant
fig
may
also
offer
trend
optim
inhibitor
water
model
superimpos
bound
molecul
equival
two
carbon
atom
residu
locat
pocket
form
hydrogen
bond
protein
includ
displac
lactam
ring
similar
bond
pattern
locat
pocket
distanc
side
chain
carbon
leu
hydrogenbond
side
chain
distanc
base
observ
new
drug
carbon
atom
replac
nitrogen
sulfur
carbon
chang
part
aldehyd
michael
addit
leu
may
replac
arg
ly
residu
interact
summari
shown
antivir
compound
inhibit
viral
proteas
thu
prevent
genom
replic
studi
reveal
key
interact
determin
bind
specif
inhibitor
proteas
inform
use
inhibitor
optim
drug
discoveri
